The company aims to raise Rs 27.52 crore via public issue of 21.5 lakh shares at the upper price band. This is purely a fresh ...

For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...

Gilead Sciences has outpaced the broader market over the past year, and analysts maintain a fairly bullish outlook on the ...

Fintel reports that on October 30, 2025, Cantor Fitzgerald maintained coverage of Vanda Pharmaceuticals (NasdaqGM:VNDA) with ...

Fintel reports that on October 30, 2025, Raymond James reiterated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a ...

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

The Russell 2500 Index was up 9.00%. The Wasatch Long/Short Alpha Fund—Investor Class did not keep pace and finished the ...

Fidelity Fundamental Large Cap Growth ETF offers high-conviction exposure to mega-cap tech & communication services. Learn ...

Exact Sciences (NASDAQ: EXAS) is gearing up to announce its quarterly earnings on Monday, 2025-11-03. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Key updates on Reliance, HDFC Bank, TCS, and more, highlighting strategic partnerships, order wins, and company developments ...

Below, we share with you three top-ranked healthcare mutual funds. Each has earned a Zacks Mutual Fund Rank #1.

In afternoon trade, the S&P/ASX 200 Index is rising, reflecting overall market positivity, while some shares are ...